Atea Pharmaceuticals
(NASDAQ) AVIR
Atea Pharmaceuticals Financials at a Glance
Market Cap
$432.62M
Revenue (TTM)
$0.00
Net Income (TTM)
$158.35M
EPS (TTM)
$-1.95
P/E Ratio
-2.78
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$5.43
Volume
421,159.939
Open
$5.37
Price
$5.43
Volume
421,159.939
Open
$5.37
Previous Close
$5.43
Daily Range
$5.34 - $5.51
52-Week Range
$2.46 - $6.45
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$5.43
Volume
421,159.939
Open
$5.37
Previous Close
$5.43
Daily Range
$5.34 - $5.51
52-Week Range
$2.46 - $6.45
AVIR News
AVIR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Atea Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
55
CEO
Jean-Pierre Sommadossi, PhD
Website
www.ateapharma.comHeadquarters
Boston, MA 02110, US
AVIR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-44%
Return on Capital
-66%
Return on Assets
-50%
Earnings Yield
-35.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$432.62M
Shares Outstanding
79.67M
Volume
421.16K
Short Interest
0.00%
Avg. Volume
552.36K
Financials (TTM)
Gross Profit
$416.00K
Operating Income
$180.89M
EBITDA
$180.89M
Operating Cash Flow
$132.03M
Capital Expenditure
$0.00
Free Cash Flow
$132.03M
Cash & ST Invst.
$301.83M
Total Debt
$843.00K
Atea Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$104.00K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$432.62M
N/A
Market Cap/Employee
$7.73M
N/A
Employees
56
N/A
Net Income
$44.87M
-33.8%
EBITDA
$54.83M
-65.1%
Quarterly Fundamentals
Net Cash
$300.99M
-33.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$843.00K
+5.4%
Return on Assets
-50.23%
N/A
Return on Invested Capital
-65.67%
N/A
Free Cash Flow
$28.22M
+7.2%
Operating Cash Flow
$28.22M
+7.2%